Prot# AVF4167g: A Multicenter, Phase II, Randomized, Blinded, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Sutent with or without Bevacizumab in First-Line Patients with Metastatic Renal Cell Cancer